Lydia A. Boateng

Overview

Lydia Boateng is a Pediatrics provider in Allentown, Pennsylvania. Her top areas of expertise are Obesity in Children, Glucose-6-Phosphate Dehydrogenase Deficiency, Increased Head Circumference, and Van Der Woude Syndrome.

Her clinical research consists of co-authoring 1 peer reviewed article and participating in 20 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution

Kwame Nkrumah University Of Science & Technology, Bachelor Of Medicine And Surgery, 2002

Residency

Pediatrics, East Tennessee State University-Quillen College Of Medicine, Johnson City, TN- 2008, 2009

Specialties

Pediatrics

Licenses

Pediatrics in PA

Board Certifications

American Board Of Pediatrics - Pediatric Hematology-Oncology
American Board Of Pediatrics - Pediatrics

Fellowships

Pediatric Hematology-Oncology, Duke University Medical Center, Durham, NC- 2010, 2011, 2012

Languages Spoken

English
French
Gaelic
Twi

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Aspirus Arise Health Plan
  • INSURANCE PLAN
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
View 15 Less Insurance Carriers -

Locations

Children's HealthCare
1517 Pond Road, Allentown, PA 18104

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


20 Clinical Trials

A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or ALK Inhibitor Therapy Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)
Umbrella Long-Term Follow-Up Protocol
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
Neuroblastoma Biology Studies
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
Key Adverse Events After Childhood Cancer
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688, NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A(MLL) Gene Rearrangement
View 16 Less Clinical Trials

1 Total Publications

Similar Doctors
Expertise in
27
conditions
Pediatrics
Expertise in
27
conditions
Pediatrics

Office

3401 Civic Center Blvd, 
Philadelphia, PA 
 (49.4 miles away)
Languages Spoken:
English

Ingo Helbig is a Pediatrics provider in Philadelphia, Pennsylvania. Dr. Helbig is highly rated in 27 conditions, according to our data. His top areas of expertise are Epilepsy, West Syndrome, Myoclonic Epilepsy, and Spasmus Nutans.

Expertise in
15
conditions
Expertise in
15
conditions

Office

3401 Civic Center Blvd, 
Philadelphia, PA 
 (49.4 miles away)
Languages Spoken:
English

Gregory Tasian is a Pediatrics provider in Philadelphia, Pennsylvania. Dr. Tasian is highly rated in 15 conditions, according to our data. His top areas of expertise are Kidney Stones, Hydronephrosis, Primary Hyperoxaluria, Ureteroscopy, and Lithotripsy.

Expertise in
37
conditions
Pediatrics | Medical Genetics
Expertise in
37
conditions
Pediatrics | Medical Genetics
34th St. & Civic Center Blvd, The Children's Hospital Of Philadelphia, Room 9nw55, 
Philadelphia, PA 
 (49.4 miles away)
Languages Spoken:
English

Elizabeth Bhoj is a Pediatrics specialist and a Medical Genetics provider in Philadelphia, Pennsylvania. Dr. Bhoj is highly rated in 37 conditions, according to our data. Her top areas of expertise are Hardikar Syndrome, Coffin-Siris Syndrome, Acheiropody, Hypotonia, and Myringotomy.

Frequently Asked Questions about Dr. Lydia A. Boateng

How do I make an appointment with Dr. Lydia A. Boateng?

You can book an appointment with Dr. Lydia A. Boateng by calling their office at 610-395-4444. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Lydia A. Boateng a top-rated expert for Obesity in Children?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Lydia A. Boateng is classified as an Experienced expert for Obesity in Children, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Lydia A. Boateng specialize in?

While Dr. Lydia A. Boateng is a Pediatrics, they have specific expertise in Obesity in Children, Glucose-6-Phosphate Dehydrogenase Deficiency, and Increased Head Circumference. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatrics.

Does Dr. Lydia A. Boateng participate in research or clinical trials?

Yes. Dr. Lydia A. Boateng has published 1 articles and abstracts on conditions like Obesity in Children. You can view a list of Dr. Lydia A. Boateng's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Lydia A. Boateng accept my insurance?

Dr. Lydia A. Boateng accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 610-395-4444 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Boateng's expertise for a condition
ConditionClose
        View All 19 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile